Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Specific (/sup 3/H)UK 14,304 binding in human cortex occurs at multiple high affinity states with alpha/sub 2/-adrenergic selectivity and differing affinities for GTP

Journal Article · · Life Sci.; (United States)
(/sup 3/H)UK 14,034 is a full agonist at ..cap alpha../sub 2/-adrenergic receptors. Although the characteristics of the binding of the partial ..cap alpha../sub 2/-adrenergic agonists in postmortem human brain were known, the binding of (/sup 3/H)UK 14,304 had not been studied in this tissue. Multi-site binding of this radiolabel had been reported in other tissues and guanosine triphosphate (GTP) had been shown to reduce (/sup 3/H)UK 14,304 binding. The authors now report that (/sup 3/H)UK 14,304 labels at least 2 specific binding sites in human brain that both have the characteristics of an ..cap alpha../sub 2/-adrenergic binding site. GTP decreases agonist binding at both of these sites, but with different potencies at each site.
Research Organization:
Case Western Reserve Univ. School of Medicine, Cleveland, OH (USA)
OSTI ID:
6244734
Journal Information:
Life Sci.; (United States), Journal Name: Life Sci.; (United States) Vol. 43:22; ISSN LIFSA
Country of Publication:
United States
Language:
English